A life-saving vaccine against meningitis B is due to be licensed for use in the UK in a move that could save thousands of lives.
The most common and deadliest form of meningitis affects an average 1870 people a year, many of them children, and results in death for one in 10 of these.
The approval of the new 4CMenB vaccine, developed by Novartis, has been hailed as the "biggest leap forward in the field in three decades" by the charity Meningitis UK.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
